APA citiranje

Gelfand, J., Abboud, H., Irani, S., Nakajima, H., Piquet, A., Pittock, S., . . . Lee, S. (2022). CIELO: A randomized, double-blind, placebo-controlled, phase 3 basket study of satralizumab in patients with NMDAR- or LGI1-antibody encephalitis. Wiley.

Chicago Style (17th ed.) Citation

Gelfand, JM, et al. CIELO: A Randomized, Double-blind, Placebo-controlled, Phase 3 Basket Study of Satralizumab in Patients with NMDAR- or LGI1-antibody Encephalitis. Wiley, 2022.

MLA citiranje

Gelfand, JM, et al. CIELO: A Randomized, Double-blind, Placebo-controlled, Phase 3 Basket Study of Satralizumab in Patients with NMDAR- or LGI1-antibody Encephalitis. Wiley, 2022.